XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Operating activities              
Net loss $ (415,878) $ (401,601) $ (474,645) $ (464,606) $ (1,169,254) $ (1,412,879)  
Adjustments to reconcile net loss to net cash used in operations              
Amortization of debt discount         48,233 27,505  
Stock issued for services         4,500 14,475  
Gain on debt settlement     (70,377)  
(Increase) decrease in              
Prepaids and other         (7,917) 11,095  
Increase (decrease) in              
Accounts payable and accrued expenses         219,332 132,687  
Accounts payable and accrued expenses - related party         588,150 557,256  
Net cash used in operating activities         (387,333) (669,861)  
Financing investing              
Proceeds from advances - related parties         3,500 429,249  
Proceeds from issuance of note payable         30,000  
Repayments on notes payable         (40,000) (40,000)  
Repayments on notes payable - related parties         (7,280) (100,000)  
Proceeds from stock issued for cash         225,200 416,500  
Collection of subscription receivable         150,000  
Net cash provided by financing activities         361,420 705,749  
Net increase (decrease) in cash         (25,913) 35,888  
Cash - beginning of period   $ 60,549   $ 1,628 60,549 1,628 $ 1,628
Cash - end of period $ 34,636   $ 37,516   34,636 37,516 $ 60,549
Supplemental disclosure of cash flow information              
Cash paid for interest         20,378 49,046  
Cash paid for income tax          
Supplemental disclosure of non-cash investing and financing activities              
Stock issued as debt discount         39,491 30,791  
Conversion of stockholder advances to notes payable - related parties         51,769 429,249  
Stock issued in settlement of accrued liabilities         155,000  
Collection of subscription receivable - warrants         16,245  
Shares issued for promissory note fees         $ 54,986